Skip to content

Efficacy and Safety of SurgiFill™ on Spinal Fusion

Clinical Trial to Evaluate the Efficacy and Safety of SurgiFill™ on Spinal Fusion -Comparison Between Autograft Mixed With SurgiFill™ and Autograft in Spinal Fusion-

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02466048
Enrollment
20
Registered
2015-06-09
Start date
2013-08-01
Completion date
2016-11-01
Last updated
2026-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fusion of Spine (Disease), Spinal Fusion Acquired

Keywords

spinal fusion, bone graft, collagen

Brief summary

This study was designed to investigate the safety and efficacy of SurgiFill™, a bone grafting material, in patients with spinal fusion.

Detailed description

This study is an open-trial study. The study will be explained to the subjects and they voluntarily agreed to participate in it. Their eligibility to participate in the study will be checked, either the right or left side of one patient will be selected for the study group, and the other, for the control group, through randomization. In the area for the study group, autogenous bones and SurgiFillTM will be grafted; and in the area for the control group, only the autogenous bones will be grafted. They will be asked to follow the guidelines of the investigators during the study and to visit the hospital seven times, including for screening. At each visit, the subjects undergo an examination with doctors, a CT scan, a X-ray, and a SPECT/CT procedure to evaluate the safety and efficacy of SurgiFill™. (\*If the subject gets surgery on the screening date, the total number of his or her visits will be six).

Interventions

PROCEDURESpinal Fusion

Spinal fusion, also known as spondylodesis or spondylosyndesis, is a surgical technique used to join two or more vertebrae. Supplementary bone tissue, from the patient (autograft), is used in conjunction with the body's natural bone growth (osteoblastic) processes to fuse the vertebrae. Either the right or left side of one patient will be selected for the study group, and the other, for the control group, through randomization. In the study group site, SurgiFill™ and the autogenous bone mixture shall be transplanted, whereas in the control group site, only the autogenous bone shall be transplanted. The autogenous bones are from iliac part.

SurgiFill™ is a gel-type high-purity ateolcollagen for bone grafting. SurgiFill™ is used with autogenous iliac graft for dorsolateral spinal fusion.

Sponsors

Sewon Cellontech Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patients who require spinal fusion 2. Adult patients aged 20 or older 3. Patients who voluntarily agreed to participate in this study and signed the informed consent form, and who do not fall into any of the

Design outcomes

Primary

MeasureTime frameDescription
Volume change of bony fusion mass in the CT1week, 6month, and 12monthA CT scan shall be conducted one week, and six and 12 months, post-operatively to calculate and record the bone integration volume. The changes in the bone integration volume shown in the CT images shall be compared and analyzed. In other words, the mean values of the experiment group's bone integration volume shown in CT images 1week, six and 12 months post-operatively shall be compared and analyzed.

Secondary

MeasureTime frameDescription
Degree change of bony fusion mass in the X-ray1month, 3month, 6month, and 12monthA radiography shall be conducted one, three, six, and 12 months post-operatively, and at the additional unscheduled visits, and the PIs from different institutions (i.e., the Seoul St. Mary's PI and the Daejon St. Mary's PI) shall cross-evaluate the results. The mean values of the experiment group's surgical site bone integration level shown in X-ray images one, three, six and 12 months post-operatively shall be compared and analyzed.
Value of ROI(Region of interest) in the SPECT/CT3monthThe osteoblastic activity levels at the surgical sites of the experiment and control groups shall be compared at three months post-operatively.
VAS Score change of Back pain questionnairescreening, 6month and 12 monthThe level of the pain (i.e., the lumbar pain and the pain radiating to the upper and lower extremities) shall be recorded using the VAS before the spondylodesis, and at six and 12 months post-operatively.
ODI Score change of Back pain questionnairescreening, 6month and 12 monthUsing the ODI score from the ODQ, the disturbances in the daily activities associated with the lumbar pain shall be compared before the spondylodesis, and at six and 12 months post-operatively.

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORYoung Hoon Kim, MD

The Catholic Univ. of Korea, Seoul St. Mary's Hospital

PRINCIPAL_INVESTIGATORYoung Yul Kim, MD

The Catholic Univ. of Korea, Daejeon St. Mary's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026